ArticleMolecular cancer2014

Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2.

Joshua C Doloff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.